RWS Holdings plc (RWS.L)
| Previous close | 184.40 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,660,001 |
| Market cap | 664.43M |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.07 |
| Earnings date | 06 June 2024 - 10 June 2024 |
| Forward dividend & yield | 0.12 (6.62%) |
| Ex-dividend date | 25 Jan 2024 |
| 1y target est | 390.00 |
Simply Wall St.RWS Holdings (LON:RWS) investors are sitting on a loss of 67% if they invested three years ago
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long...
- Business Wire
Component Content Alliance Sets New Standard in Content Development and Strategy
CHALFONT ST PETER, England, March 18, 2024--RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces the launch of the Component Content Alliance (CCA), a global community that brings together content experts, thought leaders and technical professionals to collaborate, share insights and drive innovation in component content development.
- Business Wire
Transform Pharmaceutical Authoring Processes With Fonto Integrated Authoring Platform
CHALFONT ST PETER, England, March 13, 2024--RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces the launch of the Fonto Integrated Authoring Platform (IAP), a game-changing solution designed to streamline the document creation and publishing process for the pharmaceutical industry.
